{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:42:56Z","timestamp":1793493776977,"version":"4.5.0"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T00:00:00Z","timestamp":1384387200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s10787-013-0195-3","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T04:57:59Z","timestamp":1384318679000},"page":"1-22","source":"Crossref","is-referenced-by-count":110,"title":["Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models"],"prefix":"10.1007","volume":"22","author":[{"given":"Nemat","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maree T.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,14]]},"reference":[{"key":"195_CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0165-5728(95)00124-7","volume":"63","author":"M Adelmann","year":"1995","unstructured":"Adelmann M, Wood J, Benzel I et al (1995) The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol 63:17\u201327","journal-title":"J Neuroimmunol"},{"key":"195_CR2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.pain.2004.03.025","volume":"110","author":"SA Aicher","year":"2004","unstructured":"Aicher SA, Silverman MB, Winkler CW et al (2004) Hyperalgesia in an animal model of multiple sclerosis. Pain 110:560\u2013570","journal-title":"Pain"},{"key":"195_CR3","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1191\/1352458505ms1177oa","volume":"11","author":"AH Al-Araji","year":"2005","unstructured":"Al-Araji AH, Oger J (2005) Reappraisal of Lhermitte\u2019s sign in multiple sclerosis. Mult Scler 11:398\u2013402","journal-title":"Mult Scler"},{"key":"195_CR4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1432-1033.1997.t01-2-00059.x","volume":"246","author":"S Albouz-Abo","year":"1997","unstructured":"Albouz-Abo S, Wilson JC, Bernard CC et al (1997) A conformational study of the human and rat encephalitogenic myelin oligodendrocyte glycoprotein peptides 35\u201355. Eur J Biochem 246:59\u201370","journal-title":"Eur J Biochem"},{"key":"195_CR5","doi-asserted-by":"crossref","first-page":"5666","DOI":"10.4049\/jimmunol.150.12.5666","volume":"150","author":"S Amor","year":"1993","unstructured":"Amor S, Baker D, Groome N et al (1993) Identification of a major encephalitogenic epitope of proteolipid protein (residues 56\u201370) for the induction of experimental allergic encephalomyelitis in Biozzi AB\/H and nonobese diabetic mice. J Immunol 150:5666\u20135672","journal-title":"J Immunol"},{"key":"195_CR6","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.4049\/jimmunol.156.8.3000","volume":"156","author":"S Amor","year":"1996","unstructured":"Amor S, O\u2019neill JK, Morris MM et al (1996) Encephalitogenic epitopes of myelin basic protein, proteolipid protein, myelin oligodendrocyte glycoprotein for experimental allergic encephalomyelitis induction in Biozzi ABH (H-2Ag7) mice share an amino acid motif. J Immunol 156:3000\u20133008","journal-title":"J Immunol"},{"key":"195_CR7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/WCO.0b013e3282febf58","volume":"21","author":"SM Anderton","year":"2008","unstructured":"Anderton SM, Liblau RS (2008) Regulatory T-cells in the control of inflammatory demyelinating diseases of the central nervous system. Curr Opin Neurol 21:248\u2013254","journal-title":"Curr Opin Neurol"},{"key":"195_CR8","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","volume":"17","author":"N Attal","year":"2010","unstructured":"Attal N, Cruccu G, Baron R et al (2010) EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 17:1113\u20131123","journal-title":"Eur J Neurol"},{"key":"195_CR9","doi-asserted-by":"crossref","unstructured":"Baranzini S, Mudge J, Van Velkinburgh JC et al (2010) Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature 464:1351\u20131356","DOI":"10.1038\/nature08990"},{"key":"195_CR10","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1152\/physrev.2001.81.2.871","volume":"81","author":"N Baumann","year":"2001","unstructured":"Baumann N, Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81:871\u2013927","journal-title":"Physiol Rev"},{"key":"195_CR11","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nri2190","volume":"7","author":"AG Baxter","year":"2007","unstructured":"Baxter AG (2007) The origin and application of experimental autoimmune encephalomyelitis. Nat Rev Immunol 7:904\u2013912","journal-title":"Nat Rev Immunol"},{"key":"195_CR12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s11481-013-9449-5","volume":"8","author":"F Begum","year":"2013","unstructured":"Begum F, Zhu W, Cortes C et al (2013) Elevation of tumour necrosis factor alpha in dorsal root ganglia and spinal cord is associated with neuroimmune modulation of pain in an animal model of multiple sclerosis. J Neuroimmune Pharmacol 8:677\u2013690","journal-title":"J Neuroimmune Pharmacol"},{"key":"195_CR13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-3-540-73677-6_8","volume-title":"Advances in multiple sclerosis and experimental demyelinating diseases","author":"WF Blakemore","year":"2008","unstructured":"Blakemore WF, Franklin RJM (2008) Remyelination in experimental models of toxin-induced demyelination. In: Rodriguez M (ed) Advances in multiple sclerosis and experimental demyelinating diseases. Springer, Berlin, pp 193\u2013212"},{"key":"195_CR14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-2999(01)01311-5","volume":"429","author":"EW Boddeke","year":"2001","unstructured":"Boddeke EW (2001) Involvement of chemokines in pain. Eur J Pharmacol 429:115\u2013119","journal-title":"Eur J Pharmacol"},{"key":"195_CR15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0304-3959(89)90128-0","volume":"37","author":"J Boivie","year":"1989","unstructured":"Boivie J, Leijon G, Johansson I (1989) Central post-stroke pain-a study of the mechanisms through analyses of the sensory abnormalities. Pain 37:173\u2013185","journal-title":"Pain"},{"key":"195_CR16","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/1352458507085551","volume":"14","author":"FM Boneschi","year":"2008","unstructured":"Boneschi FM, Colombo B, Annovazzi P et al (2008) Lifetime and actual prevalence of pain and headache in multiple sclerosis. Mult Scler 14:514\u2013521","journal-title":"Mult Scler"},{"key":"195_CR17","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.clinthera.2007.09.023","volume":"29","author":"B Breuer","year":"2007","unstructured":"Breuer B, Pappagallo M, Knotkova H et al (2007) A randomised, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis. Clin Ther 29:2022\u20132030","journal-title":"Clin Ther"},{"key":"195_CR18","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3171\/jns.1980.53.5.0674","volume":"53","author":"KJ Burchiel","year":"1980","unstructured":"Burchiel KJ (1980) Abnormal impulse generation in focally demyelinated trigeminal roots. J Neurosurg 53:674\u2013683","journal-title":"J Neurosurg"},{"key":"195_CR19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.brainres.2012.07.006","volume":"1472","author":"AM Campbell","year":"2012","unstructured":"Campbell AM, Zagon IS, Mclaughlin PJ (2012) Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis. Brain Res 1472:138\u2013148","journal-title":"Brain Res"},{"key":"195_CR20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0074-7742(07)79003-7","volume":"79","author":"T Chitnis","year":"2007","unstructured":"Chitnis T (2007) The role of CD4 T-cells in the pathogenesis of multiple sclerosis. Int Rev Neurobiol 79:43\u201372","journal-title":"Int Rev Neurobiol"},{"key":"195_CR21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/AJP.0b013e318190862b","volume":"25","author":"A Chitsaz","year":"2009","unstructured":"Chitsaz A, Janghorbani M, Shaygannejad V et al (2009) Sensory complaints of the upper extremities in multiple sclerosis: relative efficacy of nortriptyline and transcutaneous electrical nerve stimulation. Clin J Pain 25:281\u2013285","journal-title":"Clin J Pain"},{"key":"195_CR22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1212\/WNL.53.2.433","volume":"53","author":"C Cianchetti","year":"1999","unstructured":"Cianchetti C, Zuddas A, Randazzo AP et al (1999) Lamotrigine adjunctive therapy in painful phenomena in MS: preliminary observations. Neurology 53:433","journal-title":"Neurology"},{"key":"195_CR23","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.2174\/1381612054864993","volume":"11","author":"F Coluzzi","year":"2005","unstructured":"Coluzzi F, Mattia C (2005) Mechanism-based treatment in chronic neuropathic pain: the role of antidepressants. Curr Pharm Des 11:2945\u20132960","journal-title":"Curr Pharm Des"},{"key":"195_CR24","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502\u20131517","journal-title":"Lancet"},{"key":"195_CR25","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","volume":"164","author":"CS Constantinescu","year":"2011","unstructured":"Constantinescu CS, Farooqi N, O\u2019brien K et al (2011) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 164:1079\u20131106","journal-title":"Br J Pharmacol"},{"key":"195_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.neuro.051508.135531","volume":"32","author":"M Costigan","year":"2009","unstructured":"Costigan M, Scholz J, Woolf CJ (2009) Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 32:1\u201332","journal-title":"Annu Rev Neurosci"},{"key":"195_CR27","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1468-1331.2008.02185.x","volume":"15","author":"G Cruccu","year":"2008","unstructured":"Cruccu G, Gronseth G, Alksne J et al (2008) AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 15:1013\u20131028","journal-title":"Eur J Neurol"},{"key":"195_CR28","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.pain.2008.12.026","volume":"143","author":"G Cruccu","year":"2009","unstructured":"Cruccu G, Biasiotta A, Di Rezze S et al (2009) Trigeminal neuralgia and pain related to multiple sclerosis. Pain 143:186\u2013191","journal-title":"Pain"},{"key":"195_CR29","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1191\/1352458505ms1186oa","volume":"11","author":"CJ Silva da","year":"2005","unstructured":"da Silva CJ, Da Rocha AJ, Mendes MF et al (2005) Trigeminal involvement in multiple sclerosis: magnetic resonance imaging findings with clinical correlation in a series of patients. Mult Scler 11:282\u2013285","journal-title":"Mult Scler"},{"key":"195_CR30","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s004150170057","volume":"248","author":"G D\u2019aleo","year":"2001","unstructured":"D\u2019aleo G, Sessa E, Di Bella P et al (2001) Topiramate modulation of R3 nociceptive reflex in multiple sclerosis patients suffering paroxysmal symptoms. J Neurol 248:996\u2013999","journal-title":"J Neurol"},{"key":"195_CR31","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.neuropharm.2012.01.030","volume":"62","author":"E Lago De","year":"2012","unstructured":"De Lago E, Moreno-Martet M, Cabranes A et al (2012) Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects. Neuropharmacology 62:2299\u20132308","journal-title":"Neuropharmacology"},{"key":"195_CR32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1352458512447594","volume":"19","author":"G Disanto","year":"2013","unstructured":"Disanto G, Ramagopalan SV (2013) On the sex ratio of multiple sclerosis. Mult Scler 19:3\u20134","journal-title":"Mult Scler"},{"key":"195_CR33","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00415-003-1032-1","volume":"250","author":"DMKG study group","year":"2003","unstructured":"DMKG study group (2003) Misoprostol in the treatment of trigeminal neuralgia associated with multiple sclerosis. J Neurol 250:542\u2013555","journal-title":"J Neurol"},{"key":"195_CR34","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0306-4522(95)00451-3","volume":"71","author":"HJ Duckers","year":"1996","unstructured":"Duckers HJ, Van Dokkum RP, Verhaagen J et al (1996) Functional and neurophysiological evidence of the efficacy of trophic pharmacotherapy using an adrenocorticotrophic hormone 4-9 analogue in experimental allergic encephalomyelitis, an animal model of multiple sclerosis. Neuroscience 71:507\u2013521","journal-title":"Neuroscience"},{"key":"195_CR35","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.nbd.2013.02.007","volume":"54","author":"RC Dutra","year":"2013","unstructured":"Dutra RC, Bento AF, Leite DF et al (2013) The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: evidence for the involvement of astrocytes. Neurobiol Dis 54:82\u201393","journal-title":"Neurobiol Dis"},{"key":"195_CR36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","volume":"132","author":"RH Dworkin","year":"2007","unstructured":"Dworkin RH, O\u2019connor AB, Backonja M et al (2007) Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132:237\u2013251","journal-title":"Pain"},{"key":"195_CR37","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","volume":"85","author":"RH Dworkin","year":"2010","unstructured":"Dworkin RH, Levy RM, Mackey SC et al (2010) Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 85:S3\u2013S14","journal-title":"Mayo Clin Proc"},{"key":"195_CR38","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/jnnp.33.4.528","volume":"33","author":"ML Espir","year":"1970","unstructured":"Espir ML, Millac P (1970) Treatment of paroxysmal disorders in multiple sclerosis with carbamazepine (Tegretol). J Neurol Neurosurg Psychiatry 33:528\u2013531","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"195_CR39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jneuroim.2010.01.001","volume":"220","author":"M Esposito","year":"2010","unstructured":"Esposito M, Ruffini F, Bellone M et al (2010) Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T-cells modulation. J Neuroimmunol 220:52\u201363","journal-title":"J Neuroimmunol"},{"key":"195_CR40","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/j.1532-2149.2011.00073.x","volume":"16","author":"M Falah","year":"2012","unstructured":"Falah M, Madsen C, Holbech JV et al (2012) A randomised, placebo-controlled trial of levetiracetam in central pain in multiple sclerosis. Eur J Pain 16:860\u2013869","journal-title":"Eur J Pain"},{"key":"195_CR41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/brain\/awg007","volume":"126","author":"NB Finnerup","year":"2003","unstructured":"Finnerup NB, Johannesen IL, Fuglsang-Frederiksen A et al (2003) Sensory function in spinal cord injury patients with and without central pain. Brain 126:57\u201370","journal-title":"Brain"},{"key":"195_CR42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2009.10.015","volume":"221","author":"R Gandhi","year":"2010","unstructured":"Gandhi R, Laroni A, Weiner HL (2010) Role of the innate immune system in the pathogenesis of multiple sclerosis. J Neuroimmunol 221:7\u201314","journal-title":"J Neuroimmunol"},{"key":"195_CR43","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/awl075","volume":"129","author":"R Gold","year":"2006","unstructured":"Gold R, Linington C, Lassmann H (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70\u00a0years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129:1953\u20131971","journal-title":"Brain"},{"key":"195_CR44","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nature11307","volume":"488","author":"AP Gregory","year":"2012","unstructured":"Gregory AP, Dendrou CA, Attfield KE et al (2012) TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 488:508\u2013511","journal-title":"Nature"},{"key":"195_CR45","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archneur.1993.00540080056014","volume":"50","author":"JA Gutrecht","year":"1993","unstructured":"Gutrecht JA, Zamani AA, Slagado ED (1993) Anatomic-radiologic basis of Lhermitte\u2019s sign in multiple sclerosis. Arch Neurol 50:849\u2013851","journal-title":"Arch Neurol"},{"key":"195_CR46","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10571-009-9390-6","volume":"29","author":"A Hald","year":"2009","unstructured":"Hald A (2009) Spinal astrogliosis in pain models: cause and effects. Cell Mol Neurobiol 29:609\u2013619","journal-title":"Cell Mol Neurobiol"},{"key":"195_CR47","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1365-2362.2011.02519.x","volume":"41","author":"AE Handel","year":"2011","unstructured":"Handel AE, Lincoln MR, Ramagopalan SV (2011) Of mice and men: experimental autoimmune encephalitis and multiple sclerosis. Eur J Clin Invest 41:1254\u20131258","journal-title":"Eur J Clin Invest"},{"key":"195_CR48","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.expneurol.2009.10.009","volume":"225","author":"L Hans","year":"2010","unstructured":"Hans L (2010) Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models. Exp Neurol 225:2\u20138","journal-title":"Exp Neurol"},{"key":"195_CR49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jns.2004.10.007","volume":"228","author":"SL Hauser","year":"2005","unstructured":"Hauser SL (2005) An update on multiple sclerosis. J Neurol Sci 228:193\u2013194","journal-title":"J Neurol Sci"},{"key":"195_CR50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-2982.2003.00824.x","volume":"24","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","unstructured":"Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24:9\u2013160","journal-title":"Cephalalgia"},{"key":"195_CR51","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00002508-199212000-00008","volume":"8","author":"RM Herman","year":"1992","unstructured":"Herman RM, D\u2019luzansky SC, Ippolito R (1992) Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study. Clin J Pain 8:338\u2013345","journal-title":"Clin J Pain"},{"key":"195_CR52","doi-asserted-by":"crossref","unstructured":"Herna\u2032n MA, Olek Mj & Ascherio A (1999) Geographic variation of MS incidence in two prospective studies of US women. Neurology 53:1711\u20131718","DOI":"10.1212\/WNL.53.8.1711"},{"key":"195_CR53","doi-asserted-by":"crossref","unstructured":"Herna\u2032n MA, Jick SS, Logroscino G et al (2005) Cigarette smoking and the progression of multiple sclerosis. Brain 128:1461\u20131465","DOI":"10.1093\/brain\/awh471"},{"key":"195_CR54","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.nbd.2008.01.001","volume":"30","author":"E Herrero-Herranz","year":"2008","unstructured":"Herrero-Herranz E, Pardo LA, Gold R et al (2008) Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neurobiol Dis 30:162\u2013173","journal-title":"Neurobiol Dis"},{"key":"195_CR55","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbadis.2010.07.019","volume":"1812","author":"DW Holman","year":"2011","unstructured":"Holman DW, Klein RS, Ransohoff RM (2011) The blood-brain barrier, chemokines and multiple sclerosis. Biochim Biophys Acta 1812:220\u2013230","journal-title":"Biochim Biophys Acta"},{"key":"195_CR56","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1212\/WNL.45.7.1294","volume":"45","author":"JP Hooge","year":"1995","unstructured":"Hooge JP, Redekop WK (1995) Trigeminal neuralgia in multiple sclerosis. Neurology 45:1294\u20131296","journal-title":"Neurology"},{"key":"195_CR57","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/135245859700300407","volume":"3","author":"MK Houtchens","year":"1997","unstructured":"Houtchens MK, Richert JR, Sami A et al (1997) Open label gabapentin treatment for pain in multiple sclerosis. Mult Scler 3:250\u2013253","journal-title":"Mult Scler"},{"key":"195_CR58","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fimmu.2012.00064","volume":"3","author":"ES Huseby","year":"2012","unstructured":"Huseby ES, Huseby PG, Shah S et al (2012) Pathogenic CD8 T-cells in multiple sclerosis and its experimental models. Front Immunol 3:64","journal-title":"Front Immunol"},{"key":"195_CR59","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/glia.1111","volume":"36","author":"A Iglesias","year":"2001","unstructured":"Iglesias A, Bauer J, Litzenburger T et al (2001) T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 36:220\u2013234","journal-title":"Glia"},{"key":"195_CR60","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pharmthera.2004.11.007","volume":"106","author":"J Imitola","year":"2005","unstructured":"Imitola J, Chitnis T, Khoury SJ (2005) Cytokines in multiple sclerosis: from bench to bedside. Pharmacol Ther 106:163\u2013177","journal-title":"Pharmacol Ther"},{"key":"195_CR61","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1191\/1352458505ms1168oa","volume":"11","author":"LV Kalia","year":"2005","unstructured":"Kalia LV, O\u2019connor PW (2005) Severity of chronic pain and its relationship to quality of life in multiple sclerosis. Mult Scler 11:322\u2013327","journal-title":"Mult Scler"},{"key":"195_CR62","doi-asserted-by":"crossref","first-page":"13713","DOI":"10.3390\/ijms131013713","volume":"13","author":"A Kalinowska-Lyszczarz","year":"2012","unstructured":"Kalinowska-Lyszczarz A, Losy J (2012) The role of neurotrophins in multiple sclerosis-pathological and clinical implications. Int J Mol Sci 13:13713\u201313725","journal-title":"Int J Mol Sci"},{"key":"195_CR63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/eujp.2001.0307","volume":"6","author":"S Kalman","year":"2002","unstructured":"Kalman S, \u00d6sterberg A, S\u00f6rensen J et al (2002) Morphine responsiveness in a group of well-defined multiple sclerosis patients: a study with i.v. morphine. Eur J Pain 6:69\u201380","journal-title":"Eur J Pain"},{"key":"195_CR64","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1084\/jem.146.5.1323","volume":"146","author":"RF Kibler","year":"1977","unstructured":"Kibler RF, Fritz RB, Chou F et al (1977) Immune response of Lewis rats to peptide C1 (residues 68-88) of guinea pig and rat myelin basic proteins. J Exp Med 146:1323\u20131331","journal-title":"J Exp Med"},{"key":"195_CR65","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainres.2007.05.072","volume":"1162","author":"H Kim","year":"2007","unstructured":"Kim H, Moon C, Ahn M et al (2007) Increased phosphorylation of cyclic AMP response element-binding protein in the spinal cord of Lewis rats with experimental autoimmune encephalomyelitis. Brain Res 1162:113\u2013120","journal-title":"Brain Res"},{"key":"195_CR66","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9440(10)64537-3","volume":"157","author":"B Kornek","year":"2000","unstructured":"Kornek B, Storch MK, Weissert R et al (2000) Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157:267\u2013276","journal-title":"Am J Pathol"},{"key":"195_CR67","author":"SJ Lalor","year":"2013","unstructured":"Lalor SJ, Segal BM (2013) Th1-mediated experimental autoimmune encephalomyelitis is CXCR3-independent. Eur J Immunol. doi: 10.1002\/eji.201343499","journal-title":"Eur J Immunol"},{"key":"195_CR68","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","volume":"10","author":"A Latremoliere","year":"2009","unstructured":"Latremoliere A, Woolf CJ (2009) Central sensitisation: a generator of pain hypersensitivity by central neural plasticity. J Pain 10:895\u2013926","journal-title":"J Pain"},{"key":"195_CR69","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s004150070157","volume":"247","author":"M Leandri","year":"2000","unstructured":"Leandri M, Lundardi G, Inglese M et al (2000) Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis. J Neurol 247:556\u2013558","journal-title":"J Neurol"},{"key":"195_CR70","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jneuroim.2011.03.008","volume":"234","author":"J Li","year":"2011","unstructured":"Li J, Zhao X, Skoff R et al (2011) Differential levels of resistance to disease induction and development of relapsing experimental autoimmune encelphalomyelitis in two H-2b-restricted mouse strains. J Neuroimmunol 234:109\u2013114","journal-title":"J Neuroimmunol"},{"key":"195_CR71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2013.01.003","volume":"256","author":"A Lieu","year":"2013","unstructured":"Lieu A, Tenorio G, Kerr BJ (2013) Protein kinase C gamma (PKCgamma) as a novel marker to assess the functional status of the corticospinal tract in experimental autoimmune encephalomyelitis (EAE). J Neuroimmunol 256:43\u201348","journal-title":"J Neuroimmunol"},{"key":"195_CR72","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2011.12.018","volume":"243","author":"L Lisi","year":"2012","unstructured":"Lisi L, Navarra P, Cirocchi R et al (2012) Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis. J Neuroimmunol 243:43\u201351","journal-title":"J Neuroimmunol"},{"key":"195_CR73","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-5728(95)00153-0","volume":"63","author":"JC Lorentzen","year":"1995","unstructured":"Lorentzen JC, Issazadeh S, Storch M et al (1995) Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunised with syngeneic spinal cord and incomplete Freund\u2019s adjuvant. J Neuroimmunol 63:193\u2013205","journal-title":"J Neuroimmunol"},{"key":"195_CR74","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.0305-1846.2001.00318.x","volume":"27","author":"S Love","year":"2001","unstructured":"Love S, Gradidge T, Coakham HB (2001) Trigeminal neuralgia due to multiple sclerosis: ultrastructural findings in trigeminal rhizotomy specimens. Neuropathol Appl Neurobiol 27:238\u2013244","journal-title":"Neuropathol Appl Neurobiol"},{"key":"195_CR75","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/1742-2094-9-233","volume":"9","author":"J Lu","year":"2012","unstructured":"Lu J, Kurejova M, Wirotanseng LN et al (2012) Pain in experimental autoimmune encephalitis: a comparative study between different mouse models. J Neuroinflammation 9:233","journal-title":"J Neuroinflammation"},{"key":"195_CR76","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1212\/WNL.48.6.1714","volume":"48","author":"G Lunardi","year":"1997","unstructured":"Lunardi G, Leandri M, Albano C et al (1997) Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology 48:1714\u20131717","journal-title":"Neurology"},{"key":"195_CR77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1044-5323(02)00125-2","volume":"15","author":"DJ Mahad","year":"2003","unstructured":"Mahad DJ, Ransohoff RM (2003) The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Semin Immunol 15:23\u201332","journal-title":"Semin Immunol"},{"key":"195_CR78","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.brainresbull.2007.01.009","volume":"72","author":"LM Mao","year":"2007","unstructured":"Mao LM, Tang Q, Wang JQ (2007) Protein kinase C-regulated cAMP response element-binding protein phosphorylation in cultured rat striatal neurons. Brain Res Bull 72:302\u2013308","journal-title":"Brain Res Bull"},{"key":"195_CR79","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-5728(92)90152-B","volume":"37","author":"Y Matsumoto","year":"1992","unstructured":"Matsumoto Y, Ohmori K, Fujiwara M (1992) Microglial and astroglial reactions to inflammatory lesions of experimental autoimmune encephalomyelitis in the rat central nervous system. J Neuroimmunol 37:23\u201333","journal-title":"J Neuroimmunol"},{"key":"195_CR80","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0165-5728(92)90016-E","volume":"38","author":"BL McRae","year":"1992","unstructured":"McRae BL, Kennedy MK, Tan LJ et al (1992) Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J Neuroimmunol 38:229\u2013240","journal-title":"J Neuroimmunol"},{"key":"195_CR81","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/1352458509106856","volume":"15","author":"M Melanson","year":"2009","unstructured":"Melanson M, Miao P, Eisenstat D et al (2009) Experimental autoimmune encephalomyelitis-induced upregulation of tumor necrosis factor-alpha in the dorsal root ganglia. Mult Scler 15:1135\u20131145","journal-title":"Mult Scler"},{"key":"195_CR82","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/eji.1830250723","volume":"25","author":"I Mendel","year":"1995","unstructured":"Mendel I, Kerlero De Rosbo N, Ben-Nun A (1995) A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T-cell receptor V beta expression of encephalitogenic T-cells. Eur J Immunol 25:1951\u20131959","journal-title":"Eur J Immunol"},{"key":"195_CR83","first-page":"1","volume-title":"Classification of chronic pain. Descriptors of chronic pain syndromes and definitions of pain terms","author":"H Merskey","year":"1994","unstructured":"Merskey H, Bogduk N (1994) Classification of chronic pain. Descriptors of chronic pain syndromes and definitions of pain terms. International Association for the Study of Pain Press, Seattle, pp 1\u2013222"},{"key":"195_CR84","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/intimm\/dxs075","volume":"24","author":"N Mikami","year":"2012","unstructured":"Mikami N, Watanabe K, Hashimoto N et al (2012) Calcitonin gene-related peptide enhances experimental autoimmune encephalomyelitis by promoting Th17-cell functions. Int Immunol 24:681\u2013691","journal-title":"Int Immunol"},{"key":"195_CR85","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1016\/j.febslet.2011.03.047","volume":"585","author":"D Miljkovic","year":"2011","unstructured":"Miljkovic D, Timotijevic G, Mostarica Stojkovic M (2011) Astrocytes in the tempest of multiple sclerosis. FEBS Lett 585:3781\u20133788","journal-title":"FEBS Lett"},{"key":"195_CR86","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1191\/1352458503ms965oa","volume":"9","author":"A Minagar","year":"2003","unstructured":"Minagar A, Alexander JS (2003) Blood-brain barrier disruption in multiple sclerosis. Mult Scler 9:540\u2013549","journal-title":"Mult Scler"},{"key":"195_CR87","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00001504-199703000-00006","volume":"10","author":"S Mir","year":"1997","unstructured":"Mir S, Taylor D (1997) The adverse effects of antidepressants. Curr Opin Psychiatry 10:88\u201394","journal-title":"Curr Opin Psychiatry"},{"key":"195_CR88","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.brainresrev.2005.11.004","volume":"51","author":"G Moalem","year":"2006","unstructured":"Moalem G, Tracey DJ (2006) Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 51:240\u2013264","journal-title":"Brain Res Rev"},{"key":"195_CR89","unstructured":"Multiple Sclerosis International Federation (MSIF) (2013) What is MS [ http:\/\/www.msif.org\/about-ms\/what-is-ms-1.aspx ]. Accessed 4 May 2013"},{"key":"195_CR90","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1212\/01.WNL.0000101723.79681.38","volume":"62","author":"KL Munger","year":"2004","unstructured":"Munger KL, Sm Zhang, O\u2019reilly E et al (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology 62:60\u201365","journal-title":"Neurology"},{"key":"195_CR91","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1750-3639.2007.00101.x","volume":"18","author":"J Newcombe","year":"2008","unstructured":"Newcombe J, Uddin A, Dove R et al (2008) Glutamate receptor expression in multiple sclerosis lesions. Brain Pathol 18:52\u201361","journal-title":"Brain Pathol"},{"key":"195_CR92","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11916-010-0108-8","volume":"14","author":"TJ Nurmikko","year":"2010","unstructured":"Nurmikko TJ, Gupta S, Maclver K (2010) Multiple sclerosis-related central pain disorders. Curr Pain Headache Rep 14:189\u2013195","journal-title":"Curr Pain Headache Rep"},{"key":"195_CR93","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pain.2007.08.024","volume":"137","author":"AB O\u2019connor","year":"2008","unstructured":"O\u2019connor AB, Schwid SR, Herrmann DN et al (2008) Pain associated with multiple sclerosis: systematic review and proposed classification. Pain 137:96\u2013111","journal-title":"Pain"},{"key":"195_CR94","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pain.2008.11.002","volume":"141","author":"CJ Olechowski","year":"2009","unstructured":"Olechowski CJ, Truong JJ, Kerr BJ (2009) Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Pain 141:156\u2013164","journal-title":"Pain"},{"key":"195_CR95","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.pain.2010.03.037","volume":"149","author":"CJ Olechowski","year":"2010","unstructured":"Olechowski CJ, Parmar A, Miller B et al (2010) A diminished response to formalin stimulation reveals a role for the glutamate transporters in the altered pain sensitivity of mice with experimental autoimmune encephalomyelitis (EAE). Pain 149:565\u2013572","journal-title":"Pain"},{"key":"195_CR96","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.expneurol.2012.12.012","volume":"241","author":"CJ Olechowski","year":"2013","unstructured":"Olechowski CJ, Tenorio G, Sauve Y et al (2013) Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE). Exp Neurol 241:113\u2013121","journal-title":"Exp Neurol"},{"key":"195_CR97","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1113\/expphysiol.2012.069922","volume":"98","author":"M Osikowicz","year":"2013","unstructured":"Osikowicz M, Mika J, Przewlocka B (2013) The glutamatergic system as a target for neuropathic pain relief. Exp Physiol 98:372\u2013384","journal-title":"Exp Physiol"},{"key":"195_CR98","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejpain.2009.03.003","volume":"14","author":"A Osterberg","year":"2010","unstructured":"Osterberg A, Boivie J (2010) Central pain in multiple sclerosis-sensory abnormalities. Eur J Pain 14:104\u2013110","journal-title":"Eur J Pain"},{"key":"195_CR99","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ejpain.2004.11.005","volume":"9","author":"A Osterberg","year":"2005","unstructured":"Osterberg A, Boivie J, Thuomas KA (2005) Central pain in multiple sclerosis-prevalence and clinical characteristics. Eur J Pain 9:531\u2013542","journal-title":"Eur J Pain"},{"key":"195_CR100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jneumeth.2007.03.013","volume":"163","author":"M Peiris","year":"2007","unstructured":"Peiris M, Monteith GR, Roberts-Thomson SJ et al (2007) A model of experimental autoimmune encephalomyelitis (EAE) in C57BL\/6 mice for the characterisation of intervention therapies. J Neurosci Methods 163:245\u2013254","journal-title":"J Neurosci Methods"},{"key":"195_CR101","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0022-510X(86)90079-1","volume":"75","author":"MP Pender","year":"1986","unstructured":"Pender MP (1986a) Ascending impairment of nociception in rats with experimental allergic encephalomyelitis. J Neurol Sci 75:317\u2013328","journal-title":"J Neurol Sci"},{"key":"195_CR102","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0006-8993(86)91627-6","volume":"367","author":"MP Pender","year":"1986","unstructured":"Pender MP (1986b) Conduction block due to demyelination at the ventral root exit zone in experimental allergic encephalomyelitis. Brain Res 367:398\u2013401","journal-title":"Brain Res"},{"key":"195_CR103","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/jnr.20488","volume":"81","author":"ED Ponomarev","year":"2005","unstructured":"Ponomarev ED, Shriver LP, Maresz K et al (2005) Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J Neurosci Res 81:374\u2013389","journal-title":"J Neurosci Res"},{"key":"195_CR104","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/archneur.62.5.795","volume":"62","author":"A Prat","year":"2005","unstructured":"Prat A, Biernacki K, Saroli T et al (2005) Kinin B1 receptor expression on multiple sclerosis mononuclear cells: correlation with magnetic resonance imaging T2-weighted lesion volume and clinical disability. Arch Neurol 62:795\u2013800","journal-title":"Arch Neurol"},{"key":"195_CR105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0303-8467(02)00036-7","volume":"104","author":"M Pugliatti","year":"2002","unstructured":"Pugliatti M, Sotgiu S, Rosati G (2002) The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 104:182\u2013191","journal-title":"Clin Neurol Neurosurg"},{"key":"195_CR106","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1468-1331.2008.02406.x","volume":"16","author":"N Putzki","year":"2009","unstructured":"Putzki N, Pfriem A, Limmroth V et al (2009) Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis. Eur J Neurol 16:262\u2013267","journal-title":"Eur J Neurol"},{"key":"195_CR107","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1460-9568.2004.03514.x","volume":"20","author":"V Raghavendra","year":"2004","unstructured":"Raghavendra V, Tanga FY, Deleo JA (2004) Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur J Neurosci 20:467\u2013473","journal-title":"Eur J Neurosci"},{"key":"195_CR108","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1474-4422(10)70094-6","volume":"9","author":"S Ramagopalan","year":"2010","unstructured":"Ramagopalan S, Dobson R, Meier U et al (2010) Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol 9:727\u2013739","journal-title":"Lancet Neurol"},{"key":"195_CR109","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.neuroscience.2010.06.014","volume":"169","author":"KM Ramos","year":"2010","unstructured":"Ramos KM, Lewis MT, Morgan KN et al (2010) Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders. Neuroscience 169:1888\u20131900","journal-title":"Neuroscience"},{"key":"195_CR110","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1093\/brain\/awm219","volume":"130","author":"S Rasmussen","year":"2007","unstructured":"Rasmussen S, Wang Y, Kivis\u00e4kk P et al (2007) Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing-remitting experimental autoimmune encephalomyelitis. Brain 130:2816\u20132829","journal-title":"Brain"},{"key":"195_CR111","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1212\/WNL.45.6.1097","volume":"45","author":"AT Reder","year":"1995","unstructured":"Reder AT, Arnason BG (1995) Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue. Neurology 45:1097\u20131100","journal-title":"Neurology"},{"key":"195_CR112","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jneuroim.2006.07.010","volume":"180","author":"EK Reinke","year":"2006","unstructured":"Reinke EK, Johnson MJ, Ling C et al (2006) Substance P receptor mediated maintenance of chronic inflammation in EAE. J Neuroimmunol 180:117\u2013125","journal-title":"J Neuroimmunol"},{"key":"195_CR113","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncpneuro0949","volume":"4","author":"ASC Rice","year":"2008","unstructured":"Rice ASC (2008) Should cannabinoids be used as analgesics for neuropathic pain? Nat Rev Neurol 4:654\u2013655","journal-title":"Nat Rev Neurol"},{"key":"195_CR1001","doi-asserted-by":"crossref","unstructured":"Rodrigues DH, Sachs D, Teixeira AL (2009) Mechanical hypernociception in experimental autoimmune encephalomyelitis. Arq Neuropsiquiatr 67:78\u201381","DOI":"10.1590\/S0004-282X2009000100019"},{"key":"195_CR114","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000176753.45410.8b","volume":"65","author":"DJ Rog","year":"2005","unstructured":"Rog DJ, Nurmikko TJ, Friede T et al (2005) Randomised, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 65:812\u2013819","journal-title":"Neurology"},{"key":"195_CR115","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.clinthera.2007.09.013","volume":"29","author":"DJ Rog","year":"2007","unstructured":"Rog DJ, Nurmikko TJ, Young CA (2007) Oromucosal delta9-tetrahydrocannabinol\/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial. Clin Ther 29:2068\u20132079","journal-title":"Clin Ther"},{"key":"195_CR116","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1468-1331.2008.02496.x","volume":"16","author":"S Rossi","year":"2009","unstructured":"Rossi S, Mataluni G, Codeca C et al (2009) Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomised, placebo-controlled study. Eur J Neurol 16:360\u2013366","journal-title":"Eur J Neurol"},{"key":"195_CR117","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.mehy.2008.03.035","volume":"71","author":"D Sachs","year":"2008","unstructured":"Sachs D, Teixeira AL (2008) Up-regulation of chemokines and their receptors may contribute to pain in multiple sclerosis. Med Hypotheses 71:466\u2013467","journal-title":"Med Hypotheses"},{"key":"195_CR118","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s00415-007-0566-z","volume":"254","author":"SA Sadiq","year":"2007","unstructured":"Sadiq SA, Poopatana CA (2007) Intrathecal baclofen and morphine in multiple sclerosis patients with severe pain and spasticity. J Neurol 254:1464\u20131465","journal-title":"J Neurol"},{"key":"195_CR119","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0022-510X(98)00322-0","volume":"162","author":"M Sakurai","year":"1999","unstructured":"Sakurai M, Kanazawa I (1999) Positive symptoms in multiple sclerosis: their treatment with sodium channel blockers, lignocaine and mexiletine. J Neurol Sci 162:162\u2013168","journal-title":"J Neurol Sci"},{"key":"195_CR120","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/archneur.60.8.1082","volume":"60","author":"P Sarchielli","year":"2003","unstructured":"Sarchielli P, Greco L, Floridi A et al (2003) Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid. Arch Neurol 60:1082\u20131088","journal-title":"Arch Neurol"},{"key":"195_CR121","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbi.2013.04.011","volume":"32","author":"K Schmitz","year":"2013","unstructured":"Schmitz K, Pickert G, Wijnvoord N et al (2013) Dichotomy of CCL21 and CXCR3 in nerve injury-evoked and autoimmunity-evoked hyperalgesia. Brain Behav Immun 32:186\u2013200","journal-title":"Brain Behav Immun"},{"key":"195_CR122","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn1992","volume":"10","author":"J Scholz","year":"2007","unstructured":"Scholz J, Woolf CJ (2007) The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10:1361\u20131368","journal-title":"Nat Neurosci"},{"key":"195_CR123","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00281-009-0181-4","volume":"31","author":"B Schreiner","year":"2009","unstructured":"Schreiner B, Heppner FL, Becher B (2009) Modelling multiple sclerosis in laboratory animals. Semin Immunopathol 31:479\u2013495","journal-title":"Semin Immunopathol"},{"key":"195_CR124","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","volume":"204","author":"B Serafini","year":"2007","unstructured":"Serafini B, Rosicarelli B, Franciotta D et al (2007) Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 204:2899\u20132912","journal-title":"J Exp Med"},{"key":"195_CR125","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1177\/1352458510366857","volume":"16","author":"N Sharafaddinzadeh","year":"2010","unstructured":"Sharafaddinzadeh N, Moghtaderi A, Kashipazha D et al (2010) The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomised placebo-controlled trial. Mult Scler 16:964\u2013969","journal-title":"Mult Scler"},{"key":"195_CR126","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jpainsymman.2006.12.015","volume":"34","author":"M Silver","year":"2007","unstructured":"Silver M, Blum D, Grainger J et al (2007) Double-blind, placebo-controlled trial of Lamotrigine in combination with other medications for neuropathic pain. J Pain Symptom Manage 34:446\u2013454","journal-title":"J Pain Symptom Manage"},{"key":"195_CR127","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.it.2013.04.006","volume":"34","author":"SB Simmons","year":"2013","unstructured":"Simmons SB, Pierson ER, Lee SY et al (2013) Modelling the heterogeneity of multiple sclerosis in animals. Trends Immunol 34:410\u2013422","journal-title":"Trends Immunol"},{"key":"195_CR128","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2174\/157015911798376208","volume":"9","author":"D Siniscalco","year":"2011","unstructured":"Siniscalco D, Giordano C, Rossi F et al (2011) Role of neurotrophins in neuropathic pain. Curr Neuropharmacol 9:523\u2013529","journal-title":"Curr Neuropharmacol"},{"key":"195_CR129","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/08916939809003872","volume":"28","author":"A Slavin","year":"1998","unstructured":"Slavin A, Ewing C, Liu J et al (1998) Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. Autoimmunity 28:109\u2013120","journal-title":"Autoimmunity"},{"key":"195_CR130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbi.2008.09.004","volume":"23","author":"E Sloane","year":"2009","unstructured":"Sloane E, Ledeboer A, Seibert W et al (2009) Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy. Brain Behav Immun 23:92\u2013100","journal-title":"Brain Behav Immun"},{"key":"195_CR131","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrneurol.2011.120","volume":"7","author":"C Solaro","year":"2011","unstructured":"Solaro C, Uccelli MM (2011) Management of pain in multiple sclerosis: a pharmacological approach. Nat Rev Neurol 7:519\u2013527","journal-title":"Nat Rev Neurol"},{"key":"195_CR132","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/WNL.51.2.609","volume":"51","author":"C Solaro","year":"1998","unstructured":"Solaro C, Lunardi GL, Capello E et al (1998) An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology 51:609\u2013611","journal-title":"Neurology"},{"key":"195_CR133","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000008192","volume":"44","author":"C Solaro","year":"2000","unstructured":"Solaro C, Messmer Uccelli M, Uccelli A et al (2000) Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. Eur Neurol 44:45\u201348","journal-title":"Eur Neurol"},{"key":"195_CR134","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1212\/01.WNL.0000137047.85868.D6","volume":"63","author":"C Solaro","year":"2004","unstructured":"Solaro C, Brichetto G, Amato MP et al (2004) The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study. Neurology 63:919\u2013921","journal-title":"Neurology"},{"key":"195_CR135","first-page":"307","volume":"25","author":"C Solaro","year":"2005","unstructured":"Solaro C, Brichetto G, Battaglia MA et al (2005) Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study. Clin Neurophysiol 25:307\u2013310","journal-title":"Clin Neurophysiol"},{"key":"195_CR136","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s10072-007-0811-3","volume":"28","author":"C Solaro","year":"2007","unstructured":"Solaro C, Restivo D, Mancardi GL et al (2007) Oxcarbazepine for treating paroxysmal painful symptoms in multiple sclerosis: a pilot study. Neurol Sci 28:156\u2013158","journal-title":"Neurol Sci"},{"key":"195_CR1000","doi-asserted-by":"crossref","unstructured":"Solaro C, Boehmker M, Tanganelli P (2009) Pregabalin for treating paroxysmal painful symptoms in multiple sclerosis: a pilot study. J Neurol 256:1773\u20131774","DOI":"10.1007\/s00415-009-5203-6"},{"key":"195_CR137","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/nm1297-1394","volume":"3","author":"SS Soldan","year":"1997","unstructured":"Soldan SS, Berti R, Salem N et al (1997) Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 3:1394\u20131397","journal-title":"Nat Med"},{"key":"195_CR138","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1172\/JCI5150","volume":"103","author":"TL Sorensen","year":"1999","unstructured":"Sorensen TL, Tani M, Jensen J et al (1999) Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103:807\u2013815","journal-title":"J Clin Invest"},{"key":"195_CR139","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1212\/WNL.50.2.571","volume":"50","author":"S Sriram","year":"1998","unstructured":"Sriram S, Mitchell W, Stratton C (1998) Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS. Neurology 50:571\u2013572","journal-title":"Neurology"},{"key":"195_CR140","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4049\/jimmunol.163.1.40","volume":"163","author":"A Stefferl","year":"1999","unstructured":"Stefferl A, Brehm U, Storch M et al (1999) Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the \u201cresistant\u201d Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response. J Immunol 163:40\u201349","journal-title":"J Immunol"},{"key":"195_CR141","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1750-3639.1998.tb00194.x","volume":"8","author":"MK Storch","year":"1998","unstructured":"Storch MK, Stefferl A, Brehm U et al (1998) Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 8:681\u2013694","journal-title":"Brain Pathol"},{"key":"195_CR142","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/nprot.2006.285","volume":"1","author":"IM Stromnes","year":"2006","unstructured":"Stromnes IM (2006) Active induction of experimental allergic encephalomyelitis. Nat Protoc 1:1810\u20131819","journal-title":"Nat Protoc"},{"key":"195_CR143","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.38149.566979.AE","volume":"329","author":"KB Svendsen","year":"2004","unstructured":"Svendsen KB, Jensen TS, Bach FW (2004) Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. BMJ 329:253","journal-title":"BMJ"},{"key":"195_CR144","first-page":"2772","volume":"167","author":"KB Svendsen","year":"2005","unstructured":"Svendsen KB, Jensen TS, Bach FW (2005a) Effect of the synthetic cannabinoid dronabinol on central pain in patients with multiple sclerosis. Ugeskr Laeger 167:2772\u20132774","journal-title":"Ugeskr Laeger"},{"key":"195_CR145","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.pain.2005.01.015","volume":"114","author":"KB Svendsen","year":"2005","unstructured":"Svendsen KB, Jensen TS, Hansen HJ et al (2005b) Sensory function and quality of life in patients with multiple sclerosis and pain. Pain 114:473\u2013481","journal-title":"Pain"},{"key":"195_CR146","doi-asserted-by":"crossref","unstructured":"Thibault K, Calvino B, Pezet S (2011) Characterisation of sensory abnormalities observed in an animal model of multiple sclerosis: a behavioural and pharmacological study. Eur J Pain 15:231.e1\u2013231.e16","DOI":"10.1016\/j.ejpain.2010.07.010"},{"key":"195_CR147","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S1474-4422(10)70249-0","volume":"9","author":"AJ Thompson","year":"2010","unstructured":"Thompson AJ, Toosy AT, Ciccarelli O (2010) Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions. Lancet Neurol 9:1182\u20131199","journal-title":"Lancet Neurol"},{"key":"195_CR148","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1517\/14656566.2011.607162","volume":"12","author":"A Truini","year":"2011","unstructured":"Truini A, Galeotti F, Cruccu G (2011) Treating pain in multiple sclerosis. Expert Opin Pharmacother 12:2355\u20132368","journal-title":"Expert Opin Pharmacother"},{"key":"195_CR149","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00415-012-6579-2","volume":"260","author":"A Truini","year":"2013","unstructured":"Truini A, Barbanti P, Pozzilli C et al (2013) A mechanism-based classification of pain in multiple sclerosis. J Neurol 260:351\u2013367","journal-title":"J Neurol"},{"key":"195_CR150","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00005072-199606000-00001","volume":"55","author":"I Tsunoda","year":"1996","unstructured":"Tsunoda I, Fujinami RS (1996) Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler\u2019s murine encephalomyelitis virus. J Neuropathol Exp Neurol 55:673\u2013686","journal-title":"J Neuropathol Exp Neurol"},{"key":"195_CR151","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1750-3639.2000.tb00272.x","volume":"10","author":"I Tsunoda","year":"2000","unstructured":"Tsunoda I, Kuang LQ, Theil DJ et al (2000) Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains. Brain Pathol 10:402\u2013418","journal-title":"Brain Pathol"},{"key":"195_CR152","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0304-3959(94)00140-A","volume":"61","author":"K Vestergaard","year":"1995","unstructured":"Vestergaard K, Nielsen J, Andersen G et al (1995) Sensory abnormalities in consecutive, unselected patients with central post-stroke pain. Pain 61:177\u2013186","journal-title":"Pain"},{"key":"195_CR153","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pain.2010.09.005","volume":"152","author":"JH Vranken","year":"2011","unstructured":"Vranken JH, Hollmann MW, Van Der Vegt MH et al (2011) Duloxetine in patients with central neuropathic pain caused by spinal cord injury or stroke: a randomised, double-blind, placebo-controlled trial. Pain 152:267\u2013273","journal-title":"Pain"},{"key":"195_CR154","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","volume":"10","author":"DT Wade","year":"2004","unstructured":"Wade DT, Makela P, Robson P et al (2004) Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomised, placebo-controlled study on 160 patients. Mult Scler 10:434\u2013441","journal-title":"Mult Scler"},{"key":"195_CR1002","doi-asserted-by":"crossref","unstructured":"Wang D, Ayers MM, Catmull DV et al (2005) Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis. Glia 51:235\u2013240","DOI":"10.1002\/glia.20199"},{"key":"195_CR155","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI3022","volume":"102","author":"R Weissert","year":"1998","unstructured":"Weissert R, Wallstrom E, Storch MK et al (1998) MHC haplotype-dependent regulation of MOG-induced EAE in rats. J Clin Invest 102:1265\u20131273","journal-title":"J Clin Invest"},{"key":"195_CR156","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ddmod.2006.11.004","volume":"3","author":"H Wekerle","year":"2006","unstructured":"Wekerle H, Kurschus FC (2006) Animal models of multiple sclerosis. Drug Discov Today Dis Models 3:359\u2013367","journal-title":"Drug Discov Today Dis Models"},{"key":"195_CR157","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ana.1077","volume":"50","author":"P Werner","year":"2001","unstructured":"Werner P, Pitt D, Raine CS (2001) Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 50:169\u2013180","journal-title":"Ann Neurol"},{"issue":"392\u2013396","key":"195_CR158","first-page":"399","volume":"47","author":"J Wilbanks","year":"2012","unstructured":"Wilbanks J (2012) Disease-modifying therapies for multiple sclerosis: focus on future direction. Formulary 47(392\u2013396):399","journal-title":"Formulary"},{"key":"195_CR159","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00004691-199701000-00002","volume":"14","author":"WD Willis","year":"1997","unstructured":"Willis WD, Westlund KN (1997) Neuroanatomy of the pain system and of the pathways that modulate pain. J Clin Neurophysiol 14:2\u201331","journal-title":"J Clin Neurophysiol"},{"key":"195_CR160","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-5728(86)90027-5","volume":"12","author":"T Yamamura","year":"1986","unstructured":"Yamamura T, Namikawa T, Endoh M et al (1986) Experimental allergic encephalomyelitis induced by proteolipid apoprotein in Lewis rats. J Neuroimmunol 12:143\u2013153","journal-title":"J Neuroimmunol"},{"key":"195_CR161","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s11481-012-9370-3","volume":"7","author":"S Yuan","year":"2012","unstructured":"Yuan S, Shi Y, Tang SJ (2012) Wnt signalling in the pathogenesis of multiple sclerosis-associated chronic pain. J Neuroimmune Pharmacol 7:904\u2013913","journal-title":"J Neuroimmune Pharmacol"},{"key":"195_CR162","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/pgmj.2009.080473","volume":"87","author":"JM Zakrzewska","year":"2011","unstructured":"Zakrzewska JM, Mcmillan R (2011) Trigeminal neuralgia: the diagnosis and management of this excruciating and poorly understood facial pain. Postgrad Med J 87:410\u2013416","journal-title":"Postgrad Med J"},{"key":"195_CR163","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","volume":"45","author":"JM Zhang","year":"2007","unstructured":"Zhang JM, An J (2007) Cytokines, inflammation, and pain. Int Anesthesiol Clin 45:27\u201337","journal-title":"Int Anesthesiol Clin"},{"key":"195_CR164","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1756-6606-4-31","volume":"4","author":"M Zhuo","year":"2011","unstructured":"Zhuo M, Wu G, Wu LJ (2011) Neuronal and microglial mechanisms of neuropathic pain. Mol Brain 4:31","journal-title":"Mol Brain"},{"key":"195_CR165","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1212\/WNL.55.10.1587","volume":"55","author":"M Zvartau-Hind","year":"2000","unstructured":"Zvartau-Hind M, Din MU, Gilani A et al (2000) Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology 55:1587\u20131588","journal-title":"Neurology"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-013-0195-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-013-0195-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-013-0195-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T12:39:12Z","timestamp":1688647152000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-013-0195-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,14]]},"references-count":168,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["195"],"URL":"https:\/\/doi.org\/10.1007\/s10787-013-0195-3","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,14]]}}}